drugset / Trial / NCT05694598
Safety and Tolerability of VGR-R01 for Patients With Bietti Crystalline Dystrophy
NaSingle-groupOpen-labelTreatment
Summary
A Multicenter, Open-Label, Non-Randomized, Uncontrolled Study of VGR-R01 in Patients with Bietti Crystalline Dystrophy.
Timeline
- Start
- 2023-03-27
- Primary completion
- 2024-09-13
- Completion
- 2028-09-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VGR-R01 | Gene therapy (AAV / viral vector) | — | Other |